Dr. Reddy'S Labs Financials
NSE: DRREDDY | BSE: 500124
₹1,151.00
As on 04-Sep-2026 15:59IST
Market cap
₹96,322 Cr
Revenue (TTM)
₹33,228 Cr
P/E Ratio
29.9
P/B Ratio
2.5
Div. Yield
0.7 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
33,227.90
|
33,700.20
|
32,643.90
|
28,011.10
|
24,669.70
|
21,545.20
|
|||||
|
Total Income
|
34,650.70
|
35,058.60
|
33,741.20
|
28,905.40
|
25,725.20
|
22,029.90
|
|||||
|
Total Expenditure
|
28,088.10
|
27,246.70
|
24,096.80
|
20,078.00
|
18,320.70
|
17,777.80
|
|||||
|
EBITDA
|
5,139.80
|
6,453.50
|
8,547.10
|
7,933.10
|
6,349.00
|
3,767.40
|
|||||
|
Depreciation
|
2,119.30
|
2,058.80
|
1,703.70
|
1,470.00
|
1,250.20
|
1,165.20
|
|||||
|
EBIT
|
3,020.50
|
4,394.70
|
6,843.40
|
6,463.10
|
5,098.80
|
2,602.20
|
|||||
|
Interest
|
416.30
|
373.80
|
282.90
|
171.10
|
142.80
|
95.80
|
|||||
|
Other Income
|
1,422.80
|
1,358.40
|
1,097.30
|
894.30
|
1,055.50
|
484.70
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
4,027.00
|
5,392.70
|
7,679.50
|
7,201.00
|
6,048.50
|
3,061.40
|
|||||
|
Provision for Tax
|
857.70
|
1,235.10
|
1,954.30
|
1,623.10
|
1,541.20
|
878.90
|
|||||
|
Profit after Tax
|
3,169.30
|
4,157.60
|
5,725.20
|
5,577.90
|
4,507.30
|
2,182.50
|
|||||
|
Minority Interest
|
38.90
|
38.40
|
-70.10
|
--
|
--
|
--
|
|||||
|
Share of Associate
|
14.00
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
3,222.20
|
4,196.00
|
5,655.10
|
5,577.90
|
4,507.30
|
2,182.50
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
37,891.50
|
37,891.50
|
33,549.60
|
28,254.80
|
23,286.10
|
19,212.40
|
|||||
|
Minority Interest
|
38.90
|
339.40
|
377.80
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
3,145.10
|
926.10
|
632.90
|
-36.80
|
-278.30
|
-508.30
|
|||||
|
Current Liabilities
|
16,747.40
|
16,747.40
|
13,033.80
|
9,588.00
|
8,572.10
|
9,765.80
|
|||||
|
Total Liabilities
|
58,123.40
|
56,576.70
|
48,022.80
|
38,779.70
|
32,209.10
|
29,745.50
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
27,204.00
|
25,875.60
|
22,576.10
|
13,000.70
|
11,154.50
|
10,682.00
|
|||||
|
Current Assets
|
30,179.30
|
30,028.80
|
25,018.00
|
24,805.30
|
20,425.40
|
17,787.90
|
|||||
|
Total Assets
|
58,123.40
|
56,576.70
|
48,022.80
|
38,779.70
|
32,209.10
|
29,745.50
|
|||||
|
Total Debt*
|
--
|
7,734.10
|
4,676.60
|
2,002.00
|
1,347.20
|
3,384.50
|
|||||
|
Net Current Assets
|
13,431.90
|
13,281.40
|
11,984.20
|
15,217.30
|
11,853.30
|
8,022.10
|
|||||
|
Contingent Liabilities
|
--
|
336.14
|
83.04
|
109.10
|
107.20
|
107.60
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
5,673.70
|
4,642.80
|
4,543.30
|
5,887.50
|
2,810.80
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-6,549.30
|
-5,807.70
|
-4,028.30
|
-4,137.30
|
-2,638.70
|
|||||
|
Cash from Financing Activities
|
--
|
829.00
|
1,891.10
|
-376.30
|
-2,686.10
|
-242.20
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-46.60
|
726.20
|
138.70
|
-935.90
|
-70.10
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
38.61
|
50.25
|
67.81
|
66.88
|
54.11
|
26.23
|
|||||
|
Cash EPS (₹)
|
38.60
|
74.45
|
89.08
|
84.51
|
69.12
|
40.24
|
|||||
|
Adjusted Book Value (₹)
|
457.39
|
452.01
|
400.54
|
337.21
|
277.80
|
229.20
|
|||||
|
Dividend per Share (₹)
|
0.69
|
8.00
|
8.00
|
8.00
|
8.00
|
6.00
|
|||||
|
Cash Flow per Share (₹)
|
--
|
67.95
|
55.67
|
272.38
|
353.39
|
168.92
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
15.58
|
11.87
|
137.06
|
185.20
|
-23.91
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
13.75
|
23.25
|
26.86
|
26.22
|
14.59
|
|||||
|
ROE (%)
|
8.72
|
11.69
|
18.61
|
21.76
|
21.36
|
11.93
|
|||||
|
ROA (%)
|
5.89
|
8.03
|
13.41
|
16.08
|
15.01
|
8.08
|
|||||
|
EBIT Margin (%)
|
9.09
|
13.04
|
20.96
|
23.07
|
20.67
|
12.08
|
|||||
|
Net Margin (%)
|
9.15
|
11.86
|
16.97
|
19.30
|
17.52
|
9.91
|
|||||
|
Cash Profit Margin (%)
|
--
|
18.45
|
22.76
|
25.16
|
23.34
|
15.54
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.87
|
3.24
|
16.54
|
13.54
|
14.50
|
13.11
|
|||||
|
EBIT Growth (%)
|
-55.06
|
-35.78
|
5.88
|
26.76
|
95.94
|
-1.47
|
|||||
|
Net Profit Growth (%)
|
-43.28
|
-27.38
|
2.64
|
23.75
|
106.52
|
11.83
|
|||||
|
EPS Growth (%)
|
-43.33
|
-25.89
|
1.38
|
23.60
|
106.27
|
11.83
|
|||||
|
Book Value Growth (%)
|
--
|
12.99
|
18.78
|
21.53
|
21.35
|
8.87
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
29.89
|
24.97
|
16.87
|
3.68
|
3.42
|
32.83
|
|||||
|
Price / Book Value
|
2.52
|
2.78
|
2.86
|
3.65
|
3.33
|
3.76
|
|||||
|
Dividend Yield (%)
|
0.69
|
0.64
|
0.70
|
0.65
|
0.87
|
0.70
|
|||||
|
EV/EBITDA
|
15.35
|
13.97
|
10.12
|
11.66
|
10.35
|
17.08
|
|||||
|
Close Price (₹)
|
1,357.10
|
1,254.90
|
1,144.20
|
1,231.58
|
924.55
|
859.09
|
|||||
|
High Price (₹)
|
1,414.90
|
1,379.70
|
1,421.49
|
1,301.18
|
931.30
|
1,122.92
|
|||||
|
Low Price (₹)
|
1,148.40
|
1,020.00
|
1,092.45
|
876.68
|
757.51
|
730.80
|
|||||
|
Market Cap (₹ Cr)
|
96,322.06
|
1,04,763.81
|
95,414.86
|
1,02,669.08
|
76,994.13
|
71,642.10
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.20
|
0.14
|
0.07
|
0.06
|
0.18
|
|||||
|
Short term debt to equity ratio
|
--
|
0.16
|
0.11
|
0.05
|
0.03
|
0.14
|
|||||
|
Current Ratio
|
1.80
|
1.79
|
1.92
|
2.59
|
2.38
|
1.82
|
|||||
|
Quick Ratio
|
1.35
|
1.34
|
1.37
|
1.92
|
1.82
|
1.30
|
|||||
|
Interest Coverage
|
10.67
|
15.43
|
28.15
|
43.09
|
43.36
|
32.96
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
30.47
|
30.04
|
27.70
|
28.67
|
29.38
|
30.99
|
|||||
|
Asset Turnover
|
0.62
|
0.65
|
0.76
|
0.81
|
0.82
|
0.80
|
|||||
|
Receivable days
|
--
|
103.79
|
95.44
|
99.54
|
103.01
|
98.60
|
|||||
|
Inventory Days
|
--
|
79.94
|
75.27
|
73.12
|
73.65
|
81.57
|
|||||
|
Payable days
|
--
|
84.78
|
96.23
|
108.56
|
108.07
|
99.98
|
|||||
|
Cash Conversion Cycle
|
--
|
98.95
|
74.48
|
64.10
|
68.59
|
80.19
|